Velentium Medical Home

Katy, TexasFounded 201251–100 employeesvelentium.com

Velentium Medical is an engineering-first medical device contract development and manufacturing organization that supports products from early concept through commercial manufacturing. The company combines medical device development, cybersecurity, automated test systems, and contract manufacturing through one accountable team without handoffs or silos.

Visit velentium.com ↗

Founded: 2012
Employees: 51–100

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Recent highlights

Velentium’s most significant recent financing milestone was a $15 million debt facility announced on Jul 15, 2024 with Trinity Capital, supporting expansion of its medical-device manufacturing capabilities. On Dec 2, 2024, the company announced executive leadership transitions: Matt Hanks became CEO and Dan Purvis moved into the Chairman role, while co-founder Tim Carroll continued as COO. Randy Armstrong remained CTO and CQO, and Travis Bird continued as CFO. Velentium also acquired Oasis Testing on Jan 12, 2021, adding relevance to its automated testing offering. Its operating scope spans engineering, embedded cybersecurity, automated test systems, contract manufacturing, regulatory preparation, and postmarket support.

Market position

Velentium occupies a specialized position between a medical-device engineering consultancy and a contract development and manufacturing organization. Its focus is complex, electromechanical active devices rather than general-purpose manufacturing, with services extending from early concept and product development through testing, regulatory preparation, commercial manufacturing, and postmarket support. The combination of embedded cybersecurity and automated test systems gives the company a broader technical scope than a conventional assembly-focused manufacturer. The Oasis Testing acquisition in 2021 reinforces that testing capability. The available comparison set does not identify independent competitor companies, so a precise named competitor ranking is not supported. Instead, Velentium appears differentiated by consolidating engineering, cybersecurity, quality, testing, and manufacturing under one accountable team, reducing handoffs for device companies with technically demanding products. Its 51-100 employee range suggests a focused specialist rather than a large-scale multinational manufacturer. The $15 million Trinity Capital facility and 2026 private-equity transaction indicate access to capital for scaling, although the company’s market share, revenue, customer concentration, and commercial product portfolio remain undisclosed.

Growth & opportunities

Velentium’s trajectory shows a progression from specialist medical-device engineering toward a more integrated development and manufacturing platform. Founded in 2012 by Dan Purvis and Tim Carroll, the company expanded its offering across research and development, product development, contract manufacturing, automated testing, embedded cybersecurity, and postmarket services. The 2021 acquisition of Oasis Testing added an inorganic capability-building step. A $15 million debt financing from Trinity Capital, announced on Jul 15, 2024, provided growth capital for medical-device manufacturing. Leadership transitions announced on Dec 2, 2024 placed Matt Hanks in the CEO role and Dan Purvis in the Chairman role, while retaining experienced founders and functional leaders across operations, technology, quality, and finance. Overall, growth appears to be driven by capability integration, financing, and organizational formalization rather than publicly documented product commercialization.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes Velentium Medical Home distinct

reccy insights

What makes Velentium Medical Home distinct

01End-to-end support from early medical-device concept through commercial manufacturing
02Integrated engineering, cybersecurity, automated testing, and contract manufacturing capabilities
03Engineering-first approach for complex technical and regulatory challenges
04Founded in 2012 by Dan Purvis and Tim Carroll, with experienced leadership across operations, technology, finance, and R&D
05Culture centered on innovation, collaboration, honorable conduct, results, and continuous learning

Technology & products6

Technology & products

Medical Device Research and Development (R&D)
Comprehensive engineering and design services for medical devices from concept through development.
Medical Device Product Development
Services to design, engineer, and prepare medical devices for manufacturing and regulatory approval.
Contract Manufacturing for Medical Devices
Manufacturing services for medical devices including assembly, testing, and quality assurance.
Postmarket Services for Medical Devices
Support services for medical devices after market release including surveillance and compliance management.
Medical Device Testing Systems
Design and supply of automated test systems to verify medical device performance and compliance.
Embedded Cybersecurity Services
Cybersecurity consulting and implementation for medical devices throughout their lifecycle.

Show all 6 products

+ 3 more: Postmarket Services for Medical Devices, Medical Device Testing Systems, Embedded Cybersecurity Services

Recent updates1

Launches, partnerships and team changes from press coverage

Dec 2, 2024Team change
Velentium announced executive leadership transitions to support ongoing growth.
businesswire.com

In the Cortex

Velentium Medical Appoints Nate Porter as Chief Commercial OfficerVelentium Medical Home on LinkedIn · Feb 16, 2026

About Velentium Medical Home

Products: Medical Device Research and Development (R&D), Medical Device Product Development, Contract Manufacturing for Medical Devices, Postmarket Services for Medical Devices, Medical Device Testing Systems, Embedded Cybersecurity Services
Leadership: Dan Purvis, Chairman & Co-FounderTim Carroll, COO & Co-FounderRandy Armstrong, CTO and CQOMatt Hanks, CEO
Focus areas: Medical devices, contract development and manufacturing, medical device engineering, cybersecurity, automated testing, hardware, manufacturing, B2B
Headquarters: Katy, Texas
Founded: 2012
Employees: 51–100
Patents granted: 1 (Crunchbase)
Trademarks: 4